IGF1 is a primary mediator of GH activity and directly influences muscle hypertrophy, protein synthesis, and nutrient partitioning (Yakar et al., Endocrinology )
Some of these GLP-1s have the same main component but different brand names
Currently, once-weekly subcutaneous semaglutide 2.4 mg is approved for chronic weight management in adults with obesity, or overweight and with at least one weight-related comorbidity 17 , for reducing CV risk in adults with established cardiovascular disease (CVD) with obesity or overweight 18 , and in adolescents aged 12 years and older 19 , in conjunction with a reduced-calorie diet and increased physical activity plan
However, some individuals may experience mild flushing or warmth shortly after injection
Tell your doctor about all your other medicines, especially insulin or other diabetes medicines, such as dulaglutide, exenatide, liraglutide, Byetta, Trulicity, Victoza, and others
doi: 10.3233/MNM-200484